Entera Bio
ENTX3.0007.98% ( -0.260 )
Entera Bio (ENTX)
Entera Bio Ltd., a clinical stage company, engages in the development of oral peptides and protein replacement therapies in Israel and internationally. It devel...
- Open
- 3.260
- High
- 3.369
- Low
- 2.950
- Prev. Close
- 3.260
- Volume
- 1.58M
- Turnover
- 5.00M
- Avg Price
- 3.168
- Bid/Ask Ratio
- --
- Amplitude
- 12.85%
- 52wk High
- 4.200
- Volume Ratio
- 0.08
- Turnover Ratio
- 3.91%
Entera Bio Analyst Rating
View MoreForecast & Rating
Jun 24, 2026Price forecast
$9.00200.00%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- benzinga_article · 6 hours ago
Entera Bio Rebounds As Investors Balance Phase 3 Funding Against Dilution Risk
- StockTitan · 11 hours ago
Greenberg Traurig Advises Entera Bio in Record $275M Israeli Biotech PIPE | ENTX Stock News
- rttnews · 1 day ago, 10:34 PM
Top Biotech Gainers: GOSS To File Seralutinib NDA In Sep, OMER Gains On AZN's Loss, FBRX Acquired
- Quartr · 2 days ago, 03:11 PM
OPK: Q2 2026 revenue rose and losses narrowed, with clinical and partnership progress highlighted
- benzinga_article · 2 days ago, 12:06 PM
12 Health Care Stocks Moving In Monday's Intraday Session
- US Stock Market Update · 2 days ago, 12:00 PM
Entera Bio surges 89% on $275M private placement for EB613 trial
